
About Hexagon Nutrition
Hexagon Nutrition is a publicly listed company based in Mumbai (India) founded in 1991 by Arun Kelkar. Micronutrient premixes, clinical nutrition products, and therapeutic foods are manufactured. It operates in the Healthcare and Retail sectors. Hexagon Nutrition was last valued at $37.01 million in December 2016. Its Indian entity Hexagon Nutrition Limited reported revenue of βΉ395 Cr. Hexagon Nutrition offers products and services including Micronutrient Premix, Clinical Nutrition, and Therapeutic Nutrition. Its focus areas include Life Sciences, Nutraceuticals Tech, Medical Food and Ready To Use Therapeutic Food. Its competitors include TruNativ, Phab and Laljee Godhoo; 2 of its 3 listed competitors have raised funding.
Company details
Hexagon Nutrition was founded in 1991 in Mumbai, India, within the nutrition manufacturing sector. Micronutrient blends, incorporating vitamins and minerals, are formulated based on scientific approvals. Clinical nutrition products and therapeutic foods are produced to address nutritional needs and combat malnutrition. Operations focus on specialized formulations for various demands, with distribution centered in India.
- Market Cap₹705 Cr
HEXAGON · NSE
- Share Price₹54.11
-5.60% today
- Revenue₹383 Cr
FY 2025-26 · +17.8% YoY
- EBITDA₹52.60 Cr
Margin 13.8%
- Net Profit₹35.55 Cr
FY 2025-26 · +52.8% YoY
- P/E (TTM)17.7x
P/B 2.4x
- ROE17.8%
ROCE 22.1%
- Debt / Equity0.14
Interest cover 9.4x
- Latest Funding Round$3.64M (USD), Unspecified
Dec 2016
- InvestorsSomerset Indus Capital Partners
& 2 more
Associated legal entities of Hexagon Nutrition
Hexagon Nutrition is associated with 4 registered companies on The Company Check; the primary company is Hexagon Nutrition Limited, a listed company. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Hexagon Nutrition Limited Listed CIN L24110MH1993PLC072189 | Active | 27 May 1993 | Mumbai, Maharashtra | ₹395 Cr | 264 | 10 | View details |
| Hexagon Nutrition (International) Private Limited CIN U15146TN2012PTC089163 | Active | 26 Dec 2012 | Tuticorin, Tamil Nadu | ₹66.3 Cr | 59 | 5 | View details |
| Hexagon Nutrition (Exports) Private Limited CIN U15139MH2012PTC409199 | Active | 24 Jul 2012 | Mumbai, Maharashtra | ₹120 Cr | 101 | 6 | View details |
| Hexagon Nutrition Limited CIN U24110MH1993PLC072189 | Active | 27 May 1993 | Mumbai, Maharashtra, India | View details |
Products & Services of Hexagon Nutrition
Hexagon Nutrition offers a comprehensive portfolio of products and services, including Micronutrient Premix, Clinical Nutrition, and Therapeutic Nutrition.
Scientifically formulated blends to fill nutrition gaps globally
Balanced formulas catering to diverse nutritional demands
Products to combat malnutrition like RUTF and RUSF
Apps and channels of Hexagon Nutrition
its YouTube channel Hexagon Nutrition Limited has 703 subscribers and 30 videos.
Videos from Hexagon Nutrition
The most watched videos on Hexagon Nutrition's YouTube channel, Hexagon Nutrition Limited (703 subscribers). Click a video to play it here.
More on Hexagon Nutrition Limited.
Funding Insights of Hexagon Nutrition
- Total Rounds 1
- Last Round Unspecified β $3.64M
- First Round $3.64M
(Dec 2016)
- Investors Count 3
All 1 funding rounds of Hexagon Nutrition with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2016 | $3.64M | Unspecified | $37.01M | Somerset Indus Capital Partners |
| Date | Valuation | Stage |
|---|---|---|
| Dec 2016 | $37.01M | β’β’β’β’β’β’β’β’ |
Last known valuation $37.01M (Dec 2016). 3 investors in total: 1 institutional and 2 angel.
Investors in Hexagon Nutrition
Hexagon Nutrition has secured backing from 3 investors, including venture fund and angel investors. Prominent investors backing the company include Somerset Indus Capital Partners, Mayur Sirdesai and Mayur Sirdesai.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare investments focused on accessibility, affordability, and ESG integration in India. | 2011 | somersetinduscap.com | Mumbai, India | |
MS Mayur Sirdesai | unknown_306f069e93ad4d208 | |||
MS Mayur Sirdesai | unknown_d1edd008b50d40d7b |
Investor details for Hexagon Nutrition
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Hexagon Nutrition Limited (Hexagon Nutrition)
Hexagon Nutrition Limited is the primary company behind Hexagon Nutrition. The boards of the 3 registered companies of Hexagon Nutrition currently have 10 directors; the longest-serving is Vikram Arun Kelkar, appointed in 2005. 37 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vikram Arun Kelkar DIN 02302364 | Managing Director | 01 Sep 2005 | 21 yrs 1 mo | Hexagon Nutrition Limited, Hexagon Nutrition (International) Private Limited, Hexagon Nutrition (Exports) Private Limited |
| Nikhil Arun Kelkar DIN 02302369 | Managing Director | 21 Aug 2008 | 18 yrs 2 mo | Hexagon Nutrition Limited, Hexagon Nutrition (International) Private Limited, Hexagon Nutrition (Exports) Private Limited |
| Aditya Subhash Kelkar DIN 02312705 | Whole-time director | 26 Dec 2012 | 13 yrs 10 mo | Hexagon Nutrition (International) Private Limited, Hexagon Nutrition (Exports) Private Limited |
| Subhash Purushottam Kelkar DIN 00177280 | Managing Director | 01 Oct 2015 | 11 yrs 1 mo | Hexagon Nutrition (International) Private Limited, Hexagon Nutrition (Exports) Private Limited |
| Aparna Deepak Sakpal DIN 10345258 | Director | 31 Oct 2023 | 3 yrs | Hexagon Nutrition Limited |
| Meena Bipinchandra Mehta DIN 10974239 | Director | 05 Mar 2025 | 1 yr 7 mo | Hexagon Nutrition Limited, Hexagon Nutrition (International) Private Limited |
| Nimesh Pratap Shukla DIN 10974257 | Director | 05 Mar 2025 | 1 yr 7 mo | Hexagon Nutrition Limited, Hexagon Nutrition (Exports) Private Limited |
| Keval Mahendra Shah DIN 07649694 | Director | 20 May 2025 | 1 yr 5 mo | Hexagon Nutrition Limited |
| Payal Yash Gaglani DIN 08546549 | Director | 20 May 2025 | 1 yr 5 mo | Hexagon Nutrition Limited |
| Raghunath Dattaram Sawant DIN 11863172 | Director | 12 Aug 2026 | 2 mo | Hexagon Nutrition Limited |
People of Hexagon Nutrition
9 people are tracked at Hexagon Nutrition (6 in leadership, 3 in board & advisors).
| Name | Role | Group |
|---|---|---|
| Founder & Managing Director | Leadership | |
| Managing Director | Leadership | |
| Director Finance & IT | Leadership | |
| Chairperson & Executive Director | Leadership | |
| Managing Director | Leadership | |
| MeJoint Managing Director | Leadership | |
Ashlesha Ashok Parchure | Board Member | Board & advisors |
Chandra Prakash Jain | Board Member | Board & advisors |
Neeraj Katare | Board Member | Board & advisors |
Complete people profiles for Hexagon Nutrition
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Hexagon Nutrition
Hexagon Nutrition is a publicly listed company on the NSE with ticker symbol HEXAGON in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date12 Jun 2026
- Listed onNSE: HEXAGON
- Listed entityHexagon Nutrition Limited
- Exchange sectorHealth technology
- ISININE0JUI01012
- Share price₹71.00 (+1.97% on the day) · 2026-10-14
- Market capitalisation₹859 Cr
- Dividend yield0.43%
- Volume (last session)242,741
Financials of Hexagon Nutrition
Exchange-reported figures of Hexagon Nutrition Limited, the listed company behind Hexagon Nutrition (NSE: HEXAGON).
Financial Highlights
FY 2025-26 Β· ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | 383 | 325 | 298 | 271 | 211 |
| Revenue growth | +17.8% | +9.1% | - | +28.1% | - |
| EBITDA | 52.60 | 39.97 | 24.50 | 36.23 | 33.98 |
| EBITDA margin | +13.8% | +12.3% | +8.2% | +13.4% | +16.1% |
| Profit before tax | 51.18 | 33.69 | 19.50 | 32.44 | 31.14 |
| Net profit | 35.55 | 23.27 | 11.60 | 22.24 | 21.09 |
| Net profit margin | +9.3% | +7.2% | +3.9% | +8.2% | +10.0% |
| EPS (βΉ) | 3.43 | 2.20 | 1.10 | 2.11 | 2.07 |
| Balance sheet | |||||
| Total assets | 272 | 228 | 219 | 206 | 163 |
| Net worth | 233 | 194 | 176 | 160 | 138 |
| Total debt | 32.70 | 28.73 | 36.89 | 39.96 | 20.27 |
| Cash & bank | 17.93 | 20.02 | 23.90 | 28.09 | 22.00 |
| Net working capital | 158 | 117 | 128 | 118 | 89.38 |
| Cash flow | |||||
| Cash from operations | 6.23 | 38.47 | 23.38 | 11.38 | 28.56 |
| Cash from investing | (5.26) | (23.35) | 3.71 | (21.23) | (9.28) |
| Cash from financing | (0.42) | (19.26) | (19.13) | 15.56 | (17.81) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Revenue | 104 | 115 | 99.54 | 95.18 | 72.86 | 107 |
| Revenue growth (YoY) | +43.2% | +8.0% | - | - | - | - |
| Other income | 2.14 | 4.25 | 2.29 | 4.32 | 1.39 | 1.24 |
| EBITDA | 11.74 | 15.05 | 15.25 | 12.24 | 10.04 | 12.10 |
| EBITDA margin | +11.3% | +13.1% | +15.3% | +12.9% | +13.8% | +11.4% |
| Depreciation | 2.30 | 2.75 | 2.49 | 2.24 | 2.17 | 2.30 |
| Interest | 0.98 | 1.13 | 1.11 | 0.99 | 0.80 | 1.01 |
| Profit before tax | 10.60 | 15.42 | 13.94 | 13.33 | 8.46 | 10.03 |
| Tax | 2.53 | 4.53 | 3.51 | 3.20 | 2.01 | 2.27 |
| Net profit | 8.07 | 10.89 | 10.43 | 10.13 | 6.45 | 7.76 |
| EPS (βΉ) | 0.66 | 0.89 | 0.85 | 0.00 | 0.53 | 0.63 |
| Metrics | FY 2025-26 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | 319 | 132 | 114 | 107 | 87.10 | 98.86 |
| Revenue growth | - | +15.9% | +6.9% | +22.6% | -11.9% | - |
| EBITDA | 43.30 | 12.72 | (4.57) | 12.84 | 7.36 | 9.32 |
| EBITDA margin | +13.6% | +9.6% | -4.0% | +12.0% | +8.5% | +9.4% |
| Profit before tax | 51.25 | 13.97 | (2.63) | 12.60 | 7.48 | 7.93 |
| Net profit | 37.90 | 10.48 | 0.73 | 8.06 | 4.63 | 8.23 |
| Net profit margin | +11.9% | +7.9% | +0.6% | +7.6% | +5.3% | +8.3% |
| EPS (βΉ) | 3.10 | 0.95 | (0.28) | 0.81 | 0.51 | 0.67 |
| Balance sheet | ||||||
| Total assets | 262 | 116 | 92.28 | 92.21 | 74.63 | 74.33 |
| Net worth | 231 | 72.54 | 61.91 | 67.37 | 59.98 | 58.31 |
| Total debt | 24.96 | 40.22 | 27.62 | 22.09 | 12.38 | 14.11 |
| Cash & bank | 10.33 | 4.90 | 5.52 | 4.73 | 6.83 | 6.60 |
| Net working capital | 177 | 42.50 | 51.45 | 47.65 | 29.83 | 39.22 |
| Cash flow | ||||||
| Cash from operations | 8.36 | (2.25) | 7.16 | 0.83 | 5.00 | 10.17 |
| Cash from investing | (19.77) | (8.03) | (8.17) | (10.66) | (1.77) | (0.77) |
| Cash from financing | 10.51 | 11.15 | 2.56 | 7.16 | (4.50) | (4.81) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Revenue | 101 | 98.47 | 81.89 | 75.50 | 63.26 | 83.45 |
| Revenue growth (YoY) | +60.3% | +18.0% | - | - | - | - |
| Other income | 3.03 | 6.47 | 3.00 | 3.97 | 2.12 | 2.22 |
| Total expenses | 89.09 | 84.47 | 69.60 | 66.10 | 55.65 | 74.89 |
| EBITDA | 12.31 | 14.00 | 12.29 | 9.40 | 7.61 | 8.56 |
| EBITDA margin | +12.1% | +14.2% | +15.0% | +12.5% | +12.0% | +10.3% |
| Depreciation | 1.43 | 1.65 | 1.44 | 1.32 | 1.34 | 1.35 |
| Interest | 0.67 | 0.62 | 0.44 | 0.42 | 0.40 | 0.52 |
| Profit before tax | 13.24 | 18.20 | 13.41 | 11.63 | 7.99 | 8.91 |
| Tax | 3.40 | 4.56 | 3.54 | 2.97 | 2.02 | 2.28 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Revenue | 104 | 115 | 99.54 | 95.18 | 72.86 | 107 |
| Revenue growth (YoY) | +43.2% | +8.0% | - | - | - | - |
| Other income | 2.14 | 4.25 | 2.29 | 4.32 | 1.39 | 1.24 |
| EBITDA | 11.74 | 15.05 | 15.25 | 12.24 | 10.04 | 12.10 |
| EBITDA margin | +11.3% | +13.1% | +15.3% | +12.9% | +13.8% | +11.4% |
| Depreciation | 2.30 | 2.75 | 2.49 | 2.24 | 2.17 | 2.30 |
| Interest | 0.98 | 1.13 | 1.11 | 0.99 | 0.80 | 1.01 |
| Profit before tax | 10.60 | 15.42 | 13.94 | 13.33 | 8.46 | 10.03 |
| Tax | 2.53 | 4.53 | 3.51 | 3.20 | 2.01 | 2.27 |
| Net profit | 8.07 | 10.89 | 10.43 | 10.13 | 6.45 | 7.76 |
| EPS (βΉ) | 0.66 | 0.89 | 0.85 | 0.00 | 0.53 | 0.63 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Revenue | 383 | 325 | 298 | 271 | 211 |
| Revenue growth | +17.8% | +9.1% | - | +28.1% | - |
| Other income | 12.24 | 6.44 | 7.27 | 5.19 | 5.88 |
| Total expenses | 330 | 285 | 273 | 235 | 178 |
| Employee cost | 50.44 | 41.91 | 39.69 | 36.36 | 30.80 |
| EBITDA | 52.60 | 39.97 | 24.50 | 36.23 | 33.98 |
| EBITDA margin | +13.8% | +12.3% | +8.2% | +13.4% | +16.1% |
| Depreciation | 9.64 | 8.77 | 8.12 | 6.68 | 6.14 |
| Interest | 4.02 | 3.95 | 4.15 | 2.30 | 2.58 |
| Profit before tax | 51.18 | 33.69 | 19.50 | 32.44 | 31.14 |
| Tax | 13.24 | 9.41 | 7.29 | 9.14 | 8.29 |
| Net profit | 35.55 | 23.27 | 11.60 | 22.24 | 21.09 |
| Net profit margin | +9.3% | +7.2% | +3.9% | +8.2% | +10.0% |
| EPS (βΉ) | 3.43 | 2.20 | 1.10 | 2.11 | 2.07 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Equity & liabilities | |||||
| Share capital | 11.06 | 11.06 | 23.27 | 11.05 | 11.05 |
| Reserves & surplus | 222 | 183 | 153 | 149 | 127 |
| Shareholders' funds (net worth) | 233 | 194 | 176 | 160 | 138 |
| Minority interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Secured loans | 30.31 | 26.60 | 36.89 | 39.94 | 20.27 |
| Unsecured loans | 2.39 | 2.13 | 0.00 | 0.02 | 0.00 |
| Total debt | 32.70 | 28.73 | 36.89 | 39.96 | 20.27 |
| Total liabilities | 272 | 228 | 219 | 206 | 163 |
| Assets | |||||
| Gross block | 142 | 133 | 126 | 106 | 95.69 |
| Net block | 63.90 | 64.25 | 65.07 | 54.95 | 50.72 |
| Capital work in progress | 2.53 | 4.05 | 2.40 | 6.83 | 1.15 |
| Investments | 37.41 | 33.95 | 18.99 | 22.80 | 18.05 |
| Inventories | 83.90 | 61.21 | 79.38 | 60.66 | 59.70 |
| Sundry debtors | 81.72 | 59.82 | 48.51 | 56.47 | 40.46 |
| Cash & bank balances | 17.93 | 20.02 | 23.90 | 28.09 | 22.00 |
| Loans & advances | 20.43 | 9.14 | 7.91 | 24.00 | 17.66 |
| Total current assets | 204 | 150 | 160 | 169 | 140 |
| Total current liabilities | 46.47 | 33.02 | 31.54 | 51.06 | 50.44 |
| Net working capital | 158 | 117 | 128 | 118 | 89.38 |
| Total assets | 272 | 228 | 219 | 206 | 163 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Opening cash | 15.22 | 19.35 | 11.39 | 17.51 | 16.03 |
| Net cash from operating activities | 6.23 | 38.47 | 23.38 | 11.38 | 28.56 |
| Net cash from investing activities | (5.26) | (23.35) | 3.71 | (21.23) | (9.28) |
| Net cash from financing activities | (0.42) | (19.26) | (19.13) | 15.56 | (17.81) |
| Net change in cash | 0.55 | (4.13) | 7.97 | 5.71 | 1.48 |
| Closing cash | 17.93 | 20.02 | 23.90 | 28.09 | 22.00 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Growth | |||||
| Sales growth | +17.8% | +9.1% | - | +28.1% | - |
| EBITDA growth | +31.6% | +63.1% | - | +6.6% | - |
| PBT growth | +51.9% | +72.8% | -39.9% | +4.2% | +9997.0% |
| Net income growth | +52.8% | +100.6% | - | +5.5% | - |
| Revenue CAGR (3Y) | +12.2% | +15.4% | - | - | - |
| EBITDA CAGR (3Y) | +13.2% | +5.6% | - | - | - |
| Profitability & leverage | |||||
| Net income margin | +9.9% | +7.5% | +4.1% | +8.6% | +10.8% |
| Return on capital employed | +22.1% | +16.8% | +10.8% | +18.9% | +21.2% |
| Return on net worth | +17.8% | +13.6% | +7.5% | +15.7% | +18.0% |
| Debt / equity | 0.14 | 0.18 | 0.26 | 0.20 | 0.21 |
| Long-term debt / equity | 0.04 | 0.05 | 0.04 | 0.03 | 0.07 |
| Interest cover | 9.36 | 12.66 | 25.34 | 7.78 | 9.27 |
| Efficiency & per share | |||||
| Fixed asset turnover | 2.78 | 2.50 | 2.49 | 2.69 | 2.25 |
| Inventory turnover | 5.27 | 4.62 | 3.57 | 4.50 | 3.71 |
| Debtors turnover | 5.41 | 6.00 | 4.85 | 5.59 | 5.17 |
| EPS (βΉ) | 3.43 | 2.20 | 1.10 | 2.11 | 2.07 |
| Dividend per share (βΉ) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (βΉ) | 21.09 | 17.55 | 14.79 | 14.45 | 12.49 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Revenue | 101 | 98.47 | 81.89 | 75.50 | 63.26 | 83.45 |
| Revenue growth (YoY) | +60.3% | +18.0% | - | - | - | - |
| Other income | 3.03 | 6.47 | 3.00 | 3.97 | 2.12 | 2.22 |
| Total expenses | 89.09 | 84.47 | 69.60 | 66.10 | 55.65 | 74.89 |
| EBITDA | 12.31 | 14.00 | 12.29 | 9.40 | 7.61 | 8.56 |
| EBITDA margin | +12.1% | +14.2% | +15.0% | +12.5% | +12.0% | +10.3% |
| Depreciation | 1.43 | 1.65 | 1.44 | 1.32 | 1.34 | 1.35 |
| Interest | 0.67 | 0.62 | 0.44 | 0.42 | 0.40 | 0.52 |
| Profit before tax | 13.24 | 18.20 | 13.41 | 11.63 | 7.99 | 8.91 |
| Tax | 3.40 | 4.56 | 3.54 | 2.97 | 2.02 | 2.28 |
| Particulars | FY 2025-26 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|
| Revenue | 319 | 132 | 114 | 107 | 87.10 | 98.86 |
| Revenue growth | - | +15.9% | +6.9% | +22.6% | -11.9% | - |
| Other income | 15.57 | 5.60 | 5.98 | 2.50 | 3.32 | 2.51 |
| Total expenses | 276 | 119 | 119 | 93.90 | 79.74 | 89.54 |
| Employee cost | 0.00 | 24.33 | 25.92 | 21.27 | 18.22 | 20.35 |
| EBITDA | 43.30 | 12.72 | (4.57) | 12.84 | 7.36 | 9.32 |
| EBITDA margin | +13.6% | +9.6% | -4.0% | +12.0% | +8.5% | +9.4% |
| Depreciation | 5.74 | 2.90 | 2.65 | 2.02 | 2.18 | 2.75 |
| Interest | 1.88 | 1.45 | 1.39 | 0.72 | 1.02 | 1.15 |
| Profit before tax | 51.25 | 13.97 | (2.63) | 12.60 | 7.48 | 7.93 |
| Tax | 13.09 | 3.53 | 0.47 | 3.65 | 1.81 | 0.54 |
| Net profit | 37.90 | 10.48 | 0.73 | 8.06 | 4.63 | 8.23 |
| Net profit margin | +11.9% | +7.9% | +0.6% | +7.6% | +5.3% | +8.3% |
| EPS (βΉ) | 3.10 | 0.95 | (0.28) | 0.81 | 0.51 | 0.67 |
| Particulars | FY 2025-26 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|
| Equity & liabilities | ||||||
| Share capital | 11.06 | 11.06 | 11.06 | 11.05 | 23.26 | 23.26 |
| Reserves & surplus | 220 | 49.27 | 38.64 | 56.32 | 36.72 | 35.05 |
| Shareholders' funds (net worth) | 231 | 72.54 | 61.91 | 67.37 | 59.98 | 58.31 |
| Secured loans | 26.61 | 16.12 | 27.62 | 22.09 | 12.38 | 14.11 |
| Unsecured loans | (1.65) | 24.10 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total debt | 24.96 | 40.22 | 27.62 | 22.09 | 12.38 | 14.11 |
| Total liabilities | 262 | 116 | 92.28 | 92.21 | 74.63 | 74.33 |
| Assets | ||||||
| Gross block | 97.06 | 50.30 | 46.73 | 43.71 | 41.19 | 44.15 |
| Net block | 40.66 | 24.57 | 22.39 | 20.47 | 19.66 | 21.40 |
| Capital work in progress | 0.65 | 1.65 | 1.18 | 2.01 | 0.29 | 0.15 |
| Investments | 33.92 | 7.81 | 16.36 | 19.54 | 15.76 | 12.17 |
| Inventories | 66.16 | 27.16 | 26.95 | 27.46 | 18.71 | 16.94 |
| Sundry debtors | 77.92 | 24.35 | 23.64 | 15.18 | 13.45 | 13.57 |
| Cash & bank balances | 10.33 | 4.90 | 5.52 | 4.73 | 6.83 | 6.60 |
| Loans & advances | 66.49 | 11.27 | 28.76 | 23.79 | 9.97 | 23.80 |
| Total current assets | 221 | 67.68 | 84.87 | 71.16 | 48.96 | 60.91 |
| Total current liabilities | 43.70 | 25.18 | 33.42 | 23.51 | 19.13 | 21.69 |
| Net working capital | 177 | 42.50 | 51.45 | 47.65 | 29.83 | 39.22 |
| Total assets | 262 | 116 | 92.28 | 92.21 | 74.63 | 74.33 |
| Particulars | FY 2025-26 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|
| Opening cash | 10.67 | 3.52 | 1.97 | 4.64 | 5.91 | 2.00 |
| Net cash from operating activities | 8.36 | (2.25) | 7.16 | 0.83 | 5.00 | 10.17 |
| Net cash from investing activities | (19.77) | (8.03) | (8.17) | (10.66) | (1.77) | (0.77) |
| Net cash from financing activities | 10.51 | 11.15 | 2.56 | 7.16 | (4.50) | (4.81) |
| Net change in cash | (0.91) | 0.88 | 1.55 | (2.68) | (1.27) | 4.60 |
| Closing cash | 10.33 | 4.90 | 5.52 | 4.73 | 6.83 | 6.60 |
| Particulars | FY 2025-26 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|
| Growth | ||||||
| Sales growth | - | +15.9% | +6.9% | +22.6% | -11.9% | - |
| EBITDA growth | - | +378.3% | -135.6% | +74.5% | -21.0% | - |
| PBT growth | +266.9% | +9998.0% | - | +68.5% | -5.7% | +9997.0% |
| Net income growth | - | +1335.6% | -90.9% | +74.1% | -43.7% | - |
| Revenue CAGR (3Y) | +44.1% | +14.9% | +4.9% | - | - | - |
| EBITDA CAGR (3Y) | +50.0% | +20.0% | - | - | - | - |
| Profitability & leverage | ||||||
| Net income margin | +12.0% | +7.9% | -2.7% | +8.4% | +6.5% | +7.5% |
| Return on capital employed | - | +14.8% | +2.4% | +14.4% | +9.6% | +14.3% |
| Return on net worth | - | +15.6% | +1.1% | +14.0% | +9.9% | +19.5% |
| Debt / equity | - | 0.50 | 0.38 | 0.27 | 0.22 | 0.28 |
| Long-term debt / equity | - | 0.04 | 0.03 | 0.04 | 0.07 | 0.11 |
| Interest cover | 5.01 | 14.77 | -19.25 | 6.65 | 19.69 | 17.50 |
| Efficiency & per share | ||||||
| Fixed asset turnover | - | 2.72 | 2.52 | 2.51 | 2.04 | 2.24 |
| Inventory turnover | - | 4.89 | 4.19 | 4.62 | 4.89 | 6.10 |
| Debtors turnover | - | 5.51 | 5.88 | 7.46 | 6.45 | 5.46 |
| EPS (βΉ) | 3.10 | 0.95 | (0.28) | 0.81 | 0.51 | 0.67 |
| Dividend per share (βΉ) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (βΉ) | 0.00 | 5.45 | 4.49 | 6.10 | 4.32 | 4.17 |
Timeline of Hexagon Nutrition
4 dated milestones of Hexagon Nutrition across 35 years, from founding to its latest funding, stage changes and deals.
- Founded Hexagon Nutrition is founded.
- Funding First funding round of $3.6M.
- Milestone Reaches Minicorn status.
- IPO Lists on the stock exchange (IPO).
Competitors of Hexagon Nutrition
Hexagon Nutrition has 3 listed competitors in our database, 2 of them funded. They include TruNativ, Phab and Laljee Godhoo.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| trunativ.co | 2019 | Mumbai, India | $3.51M | 29 | Natural nutrition and wellness products are sold online by TruNativ. | |
| getphab.com | 2018 | Mumbai, India | $7.58M | 90 | Brand of protein powder | |
| laljeegodhoo.com | 1894 | Mumbai, India | 43 | Provides online sales of authentic Asafoetida and blended spices products. |
Detailed competitors of Hexagon Nutrition
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Hexagon Nutrition
The website of Hexagon Nutrition (hexagonnutrition.com) receives about 2.6K visits a month.
- Monthly visits2.6K
▲ 20.2% vs previous month
Websites whose visitors overlap most with Hexagon Nutrition. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
medplus-health.com | medplus-health.com | 100% | β | ||
nutra-balance-products.com | nutra-balance-products.com | 100% | β | ||
nestleclinicalnutrition.com | nestleclinicalnutrition.com | 100% | β | ||
| dehly.ch | 100% | View details | |||
covex.com | covex.com | 100% | #8,283,914 | β | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 17 similar websites and full traffic analytics for Hexagon Nutrition
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 17 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Nutraceutical & Food-as-Medicine Platforms
3 companies that operate in the same segment as Hexagon Nutrition (Nutraceutical & Food-as-Medicine Platforms) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Ayurvedic healthcare and nutritional products are provided by Kapiva. | 2016 | Bengaluru, Karnataka, India | USD 77.85 M | USD 27.35 M | 362 | |
Nutritional supplements for multiple health ailments are developed. | 2005 | Mumbai, Maharashtra, India | USD 1.55 M | |||
Nutritional food and health supplements are provided by OZiva. | 2010 | Mumbai, Maharashtra, India | USD 17.32 M | USD 23.98 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Hexagon Nutrition
Complete news archive for Hexagon Nutrition
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hexagon Nutrition
Hexagon Nutrition was founded in 1991 and raised its 1st funding round 25 years after it was founded.
Hexagon Nutrition is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Hexagon Nutrition, Hexagon Nutrition Limited, reported revenue of βΉ395 Cr for FY 2026, up 18% year on year.
Hexagon Nutrition was founded in 1991 in Mumbai, India, within the nutrition manufacturing sector. Micronutrient blends, incorporating vitamins and minerals, are formulated based on scientific approvals. Clinical nutrition products and therapeutic foods are produced to address nutritional needs and combat malnutrition. Operations focus on specialized formulations for various demands, with distribution centered in India.
Hexagon Nutrition's top competitors include TruNativ, Phab and Laljee Godhoo.
Hexagon Nutrition offers Micronutrient Premix, Clinical Nutrition, and Therapeutic Nutrition.
Yes, Hexagon Nutrition is publicly traded on NSE under the ticker symbol HEXAGON.
Hexagon Nutrition has 3 investors. Key investors include Somerset Indus Capital Partners, Mayur Sirdesai, and Mayur Sirdesai.
The valuation of Hexagon Nutrition is $37.01M as of Dec 2016.
Hexagon Nutrition is associated with 3 legal entities: Hexagon Nutrition Limited, Hexagon Nutrition (International) Private Limited, Hexagon Nutrition (Exports) Private Limited.
The legal entities of Hexagon Nutrition currently have 13 directors, including Vikram Arun Kelkar, Nikhil Arun Kelkar, Keval Mahendra Shah and others.
